Literature DB >> 6831772

Studies of mononuclear phagocyte function in the rat. I. Saturation and recovery following intravenous administration of soluble human serum albumin (HSA)--anti-HSA complexes.

J T Bourne, W J Raynor, J Verrier Jones.   

Abstract

We have attempted to demonstrate saturation of the mononuclear phagocyte system (MPS) in the Long Evans rat following intravenous administration of increasing doses of soluble HSA--125I-anti-HSA complexes. The fate of large (greater than 11S) complexes was followed by sucrose density gradient ultracentrifugation of serial serum samples in rats receiving 0.005-0.16 mg anti-HSA/g body weight. Administration of complexes provoked a rapid and profound increase in vascular permeability. Under these conditions no steady state clearance velocity for greater than 11S complexes could be established. The quantity of greater than 11S complexes removed from the circulation in the 1st hr never became independent of the initial dose. Specific immune complex uptake by the liver reached a maximum in rats receiving 0.09 mg anti-HSA/g body weight. Above this dose specific uptake decreased. Clearance of a tracer dose of complexes in rats pre-loaded with complexes containing 0.06 mg anti-HSA/g body weight was delayed for more than 3 hr. This was cautiously interpreted to indicate the period required for MPS recovery. The pattern of immune complex clearance in the context of marked changes in vascular permeability raised the possibility that maximum uptake was determined not by saturation of the mononuclear phagocyte system but by impaired hepatic perfusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6831772      PMCID: PMC1536745     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes.

Authors:  A O Haakenstad; J B Case; M Mannik
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

2.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

3.  Reticuloendothelial system function. V. Studies on the correlation between phagocytic rate and liver blood flow.

Authors:  S J Normann
Journal:  J Reticuloendothel Soc       Date:  1972-11

4.  Disappearance and recovery of human monocyte IgG receptor activity after phagocytosis.

Authors:  M E Schmidt; S D Douglas
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

5.  Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.

Authors:  M M Frank; M I Hamburger; T J Lawley; R P Kimberly; P H Plotz
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

6.  Studies of reticuloendothelial function in the mouse with model immune complexes. II. Serum clearance, tissue uptake, and reticuloendothelial saturation in NZB/W mice.

Authors:  D S Finbloom; P H Plotz
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

7.  An enzymic method for the trace iodination of immunoglobulins and other proteins.

Authors:  J J Marchalonis
Journal:  Biochem J       Date:  1969-06       Impact factor: 3.857

8.  Plasmapheresis in the management of acute systemic lupus erythematosus?

Authors:  J V Jones; R H Cumming; R C Bucknall; C M Asplin
Journal:  Lancet       Date:  1976-04-03       Impact factor: 79.321

9.  Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange.

Authors:  C M Lockwood; S Worlledge; A Nicholas; C Cotton; D K Peters
Journal:  N Engl J Med       Date:  1979-03-08       Impact factor: 91.245

10.  Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation.

Authors:  M Mannik; M P Arend; A P Hall; B C Gilliland
Journal:  J Exp Med       Date:  1971-04-01       Impact factor: 14.307

View more
  1 in total

1.  Immune complex-induced enteropathy in the rat. I. Clinical and histological features.

Authors:  S E Kirkham; K J Bloch; M B Bloch; R P Perry; W A Walker
Journal:  Dig Dis Sci       Date:  1986-07       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.